Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple myeloma--an update on diagnosis and treatment.
Caers J, Vande broek I, De Raeve H, Michaux L, Trullemans F, Schots R, Van Camp B, Vanderkerken K. Caers J, et al. Among authors: schots r. Eur J Haematol. 2008 Nov;81(5):329-43. doi: 10.1111/j.1600-0609.2008.01127.x. Epub 2008 Sep 13. Eur J Haematol. 2008. PMID: 18637123 Review.
Recent advances in myeloma treatment.
Schots R. Schots R. Transfus Apher Sci. 2011 Apr;44(2):223-9. doi: 10.1016/j.transci.2011.01.018. Epub 2011 Feb 23. Transfus Apher Sci. 2011. PMID: 21349768
Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model.
Nur H, Fostier K, Aspeslagh S, Renmans W, Bertrand E, Leleu X, Favreau M, Breckpot K, Schots R, De Waele M, Van Valckenborgh E, De Bruyne E, Facon T, Elewaut D, Vanderkerken K, Menu E. Nur H, et al. Among authors: schots r. PLoS One. 2013 May 31;8(5):e65075. doi: 10.1371/journal.pone.0065075. Print 2013. PLoS One. 2013. PMID: 23741460 Free PMC article.
Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation.
De Keersmaecker B, Fostier K, Corthals J, Wilgenhof S, Heirman C, Aerts JL, Thielemans K, Schots R. De Keersmaecker B, et al. Among authors: schots r. Cancer Immunol Immunother. 2014 Oct;63(10):1023-36. doi: 10.1007/s00262-014-1571-6. Epub 2014 Jun 20. Cancer Immunol Immunother. 2014. PMID: 24947180 Free PMC article.
Cellular immunotherapy in multiple myeloma: lessons from preclinical models.
Binsfeld M, Fostier K, Muller J, Baron F, Schots R, Beguin Y, Heusschen R, Caers J. Binsfeld M, et al. Among authors: schots r. Biochim Biophys Acta. 2014 Dec;1846(2):392-404. doi: 10.1016/j.bbcan.2014.08.001. Epub 2014 Aug 7. Biochim Biophys Acta. 2014. PMID: 25109893 Free article. Review.
The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma.
Faict S, Oudaert I, D'Auria L, Dehairs J, Maes K, Vlummens P, De Veirman K, De Bruyne E, Fostier K, Vande Broek I, Schots R, Vanderkerken K, Swinnen JV, Menu E. Faict S, et al. Among authors: schots r. Cancers (Basel). 2019 Nov 20;11(12):1823. doi: 10.3390/cancers11121823. Cancers (Basel). 2019. PMID: 31756922 Free PMC article.
108 results